These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19213579)

  • 1. Re: Clinical endpoints in peripheral endovascular revascularisation trials: a case for standardized definitions.
    Golledge J; Leicht A; Crowther R; Askew C; Gibbs H; Walker PJ
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):497; author reply 497-8. PubMed ID: 19213579
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions.
    Diehm N; Pattynama PM; Jaff MR; Cremonesi A; Becker GJ; Hopkins LN; Mahler F; Talen A; Cardella JF; Ramee S; van Sambeek M; Vermassen F; Biamino G
    Eur J Vasc Endovasc Surg; 2008 Oct; 36(4):409-19. PubMed ID: 18692415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Mehta T, Venkata Subramaniam A, Chetter I, McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg 2006;31:46-52.
    Chong PF; Garratt AM; Greenhalgh RM; Davies AH
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):110-1; author reply 110. PubMed ID: 16584901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of the quality of life of patients with peripheral vascular diseases].
    Wohlgemuth WA; Niechzial M; Nagel E; Bohndorf K
    Rofo; 2003 Feb; 175(2):169-75. PubMed ID: 12584614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on "Clinical endpoints in peripheral endovascular revascularisation trials: a case for standardised definitions Eur J Vasc Endovasc Surg 2008;36:409-9".
    Breek JC; De Vries J; Hamming JF
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):371. PubMed ID: 19111483
    [No Abstract]   [Full Text] [Related]  

  • 6. The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT) - The 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Breek JC; De Vries J; Hamming JF
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):378. PubMed ID: 17582794
    [No Abstract]   [Full Text] [Related]  

  • 7. Balloon angioplasty or nitinol stents for peripheral-artery disease.
    Golledge J; Norman P
    N Engl J Med; 2006 Aug; 355(5):522; author reply 523-4. PubMed ID: 16888843
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing the "correct" assessment tool.
    Smith DJ; Huntington J
    Curr Probl Cancer; 2006; 30(6):272-82. PubMed ID: 17123879
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome assessment for intermittent claudication.
    Golledge J; Askew C; Leicht A; Oldenburg B
    Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):44-5. PubMed ID: 16202628
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor, re: Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12.
    Dregelid E
    Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):761. PubMed ID: 17433731
    [No Abstract]   [Full Text] [Related]  

  • 11. Dealing with multiple endpoints.
    Dueck A; Novotny PJ
    Curr Probl Cancer; 2006; 30(6):298-306. PubMed ID: 17123881
    [No Abstract]   [Full Text] [Related]  

  • 12. Analyzing the "correct" endpoint.
    Atherton PJ; Novotny PJ; Tan AD
    Curr Probl Cancer; 2006; 30(6):283-97. PubMed ID: 17123880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life following percutaneous transluminal angioplasty for claudication.
    Tisi PV; Shearman CP
    Eur J Vasc Endovasc Surg; 1996 Nov; 12(4):509-10. PubMed ID: 8980451
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcome measures of specific immunotherapy.
    Pfaar O; Anders C; Klimek L
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):208-13. PubMed ID: 19365259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioplasty for intermittent claudication: has the balloon finally burst?
    Buckenham T
    N Z Med J; 2003 Jan; 116(1168):U304. PubMed ID: 12601427
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral angioplasty steps out.
    Pollner F
    Med World News; 1987 Dec; 28(23):30-8. PubMed ID: 10317992
    [No Abstract]   [Full Text] [Related]  

  • 18. Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?
    Cohn J; Cleland JG; Lubsen J; Borer JS; Steg PG; Perelman M; Zannad F
    J Card Fail; 2009 Apr; 15(3):199-205. PubMed ID: 19327621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures of quality of life: summary.
    Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S25. PubMed ID: 12396798
    [No Abstract]   [Full Text] [Related]  

  • 20. An approach to cultural adaptation and validation: the Intermittent Claudication Questionnaire.
    Ketenci B; Tuygun AK; Gorur A; Bicer M; Ozay B; Gunay R; Guney MR; Sargin M; Cimen S; Demirtas MM; Yekeler I
    Vasc Med; 2009 May; 14(2):117-22. PubMed ID: 19366817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.